145 related articles for article (PubMed ID: 32946796)
1. Ubiquitin-like protein FAT10: A potential cardioprotective factor and novel therapeutic target in cancer.
Zhang K; Chen L; Zhang Z; Cao J; He L; Li L
Clin Chim Acta; 2020 Nov; 510():802-811. PubMed ID: 32946796
[TBL] [Abstract][Full Text] [Related]
2. FAT10 attenuates hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3.
Zhou Q; Peng X; Liu X; Chen L; Xiong Q; Shen Y; Xie J; Xu Z; Huang L; Hu J; Wan R; Hong K
J Mol Cell Cardiol; 2018 Mar; 116():115-124. PubMed ID: 29438664
[TBL] [Abstract][Full Text] [Related]
3. Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression.
Yan J; Lei J; Chen L; Deng H; Dong D; Jin T; Liu X; Yuan R; Qiu Y; Ge J; Peng X; Shao J
Hepatology; 2018 Dec; 68(6):2268-2284. PubMed ID: 29790184
[TBL] [Abstract][Full Text] [Related]
4. FAT10ylation as a signal for proteasomal degradation.
Schmidtke G; Aichem A; Groettrup M
Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
[TBL] [Abstract][Full Text] [Related]
5. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.
Liu L; Dong Z; Liang J; Cao C; Sun J; Ding Y; Wu D
Oncogene; 2014 Feb; 33(7):909-20. PubMed ID: 23812429
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-like protein FAT10 in hepatocellular carcinoma cells limits the efficacy of anti-VEGF therapy.
Qiu Y; Che B; Zhang W; Zhang AV; Ge J; Du D; Li J; Peng X; Shao J
J Adv Res; 2024 May; 59():97-109. PubMed ID: 37328057
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
Bialas J; Groettrup M; Aichem A
PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
Dong D; Jiang W; Lei J; Chen L; Liu X; Ge J; Che B; Xi X; Shao J
Oncotarget; 2016 Dec; 7(49):81463-81473. PubMed ID: 27806337
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract][Full Text] [Related]
11. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
Aichem A; Catone N; Groettrup M
FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
[TBL] [Abstract][Full Text] [Related]
12. FAT10 protects cardiac myocytes against apoptosis.
Peng X; Shao J; Shen Y; Zhou Y; Cao Q; Hu J; He W; Yu X; Liu X; Marian AJ; Hong K
J Mol Cell Cardiol; 2013 Jun; 59():1-10. PubMed ID: 23416168
[TBL] [Abstract][Full Text] [Related]
13. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
[TBL] [Abstract][Full Text] [Related]
15. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.
Roverato ND; Sailer C; Catone N; Aichem A; Stengel F; Groettrup M
Cell Rep; 2021 Mar; 34(11):108857. PubMed ID: 33730565
[TBL] [Abstract][Full Text] [Related]
16. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
[TBL] [Abstract][Full Text] [Related]
17. FAT10: Function and Relationship with Cancer.
Xiang S; Shao X; Cao J; Yang B; He Q; Ying M
Curr Mol Pharmacol; 2020; 13(3):182-191. PubMed ID: 31729307
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-like modifier FAT10 in cancer development.
Aichem A; Groettrup M
Int J Biochem Cell Biol; 2016 Oct; 79():451-461. PubMed ID: 27393295
[TBL] [Abstract][Full Text] [Related]
19. NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective.
Arshad M; Abdul Hamid N; Chan MC; Ismail F; Tan GC; Pezzella F; Tan KL
Cells; 2021 Aug; 10(9):. PubMed ID: 34571823
[TBL] [Abstract][Full Text] [Related]
20. GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway.
Luo C; Xiong H; Chen L; Liu X; Zou S; Guan J; Wang K
Exp Cell Res; 2018 Apr; 365(1):1-11. PubMed ID: 29458176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
